title: Pediatric high-grade astrocytomas: a distinct neuro-oncological paradigm.
abstract: Brain tumors are the leading cause of cancer-related death in children. High-grade astrocytomas (HGAs), in particular, are lethal in children across all ages. Integrative genome-wide analyses of the tumor's genome, transcriptome and epigenome, using next-generation sequencing technologies and genome-wide DNA methylation arrays, have provided valuable breakthroughs in our understanding of the pathogenesis of HGAs across all ages. Recent profiling studies have provided insight into the epigenetic nature of gliomas in young adults and HGAs in children, particularly with the identification of recurrent gain-of-function driver mutations in the isocitrate dehydrogenase 1 and 2 genes (IDH1/2) and the epigenetic influence of their oncometabolite 2-hydroxyglutarate, as well as mutations in the histone 3 variant 3 gene (H3F3A) and loss-of-function mutations in the histone 3 lysine 36 trimethyltransferase gene (SETD2). Mutations in H3F3A result in amino acid substitutions at residues thought to directly (K27M) or indirectly (G34R/V) affect histone post-translational modifications, suggesting they have the capacity to affect the epigenome in a profound manner. Here, we review recent genomic studies, and discuss evidence supporting the molecular characterization of pediatric HGAs to complement traditional approaches, such as histology of resected tumors. We also describe newly identified molecular mechanisms and discuss putative therapeutic approaches for HGAs specific to pediatrics, highlighting the necessity for the evolution of HGA disease management approaches.
authors.affiliation: Departments of Pediatrics and Human Genetics, McGill University and McGill University Health Centre, Montreal, Quebec, Canada, H3Z2Z3.
authors.forename: Noha
authors.initials: N
authors.lastname: Gerges
authors.affiliation: Division of Experimental Medicine, McGill University and McGill University Health Centre, Montreal, Quebec, Canada, H3Z2Z3.
authors.forename: Adam M
authors.initials: AM
authors.lastname: Fontebasso
authors.affiliation: Department of Pathology, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada, H3H1P3.
authors.forename: Steffen
authors.initials: S
authors.lastname: Albrecht
authors.affiliation: Departments of Pediatrics and Human Genetics, McGill University and McGill University Health Centre, Montreal, Quebec, Canada, H3Z2Z3.
authors.forename: Damien
authors.initials: D
authors.lastname: Faury
authors.affiliation: Departments of Pediatrics and Human Genetics, McGill University and McGill University Health Centre, Montreal, Quebec, Canada, H3Z2Z3 ; Division of Experimental Medicine, McGill University and McGill University Health Centre, Montreal, Quebec, Canada, H3Z2Z3.
authors.forename: Nada
authors.initials: N
authors.lastname: Jabado
references.citation: Cell. 2013 May 23;153(5):1064-79
references.pmid: 23706743
references.citation: Nature. 2012 Aug 2;488(7409):100-5
references.pmid: 22832583
references.citation: Genome Res. 2011 Apr;21(4):505-14
references.pmid: 21393386
references.citation: Neuro Oncol. 2012 Nov;14 Suppl 5:v1-49
references.pmid: 23095881
references.citation: Brain Pathol. 2013 Sep;23(5):558-64
references.pmid: 23414300
references.citation: Nature. 2012 Feb 15;483(7390):474-8
references.pmid: 22343901
references.citation: Clin Cancer Res. 2007 Feb 15;13(4):1253-9
references.pmid: 17317837
references.citation: J Clin Invest. 2008 May;118(5):1739-49
references.pmid: 18398503
references.citation: Genes Dev. 2013 May 1;27(9):985-90
references.pmid: 23603901
references.citation: Science. 2012 Nov 23;338(6110):1080-4
references.pmid: 23087000
references.citation: Science. 2012 Sep 7;337(6099):1231-5
references.pmid: 22837387
references.citation: Cancer Res. 2008 Nov 1;68(21):8673-7
references.pmid: 18974108
references.citation: J Neurooncol. 2013 Mar;112(1):67-72
references.pmid: 23354654
references.citation: J Clin Oncol. 2007 Oct 20;25(30):4722-9
references.pmid: 17947719
references.citation: Br J Cancer. 2009 Aug 18;101(4):722-33
references.pmid: 19603027
references.citation: J Neurooncol. 2005 Dec;75(3):267-72
references.pmid: 16195804
references.citation: Science. 2013 May 17;340(6134):857-61
references.pmid: 23539183
references.citation: J Clin Oncol. 2011 Apr 10;29(11):1408-14
references.pmid: 20823417
references.citation: Nat Genet. 2013 Jun;45(6):602-12
references.pmid: 23583981
references.citation: Cancer Cell. 2010 Jan 19;17(1):98-110
references.pmid: 20129251
references.citation: Cancer Cell. 2010 May 18;17(5):510-22
references.pmid: 20399149
references.citation: Nat Rev Cancer. 2012 Dec;12(12):818-34
references.pmid: 23175120
references.citation: Proc Natl Acad Sci U S A. 2013 May 14;110(20):8188-93
references.pmid: 23633565
references.citation: Acta Neuropathol. 2011 Jun;121(6):763-74
references.pmid: 21424530
references.citation: Nat Genet. 2013 Aug;45(8):927-32
references.pmid: 23817572
references.citation: J Neuropathol Exp Neurol. 2005 Jun;64(6):479-89
references.pmid: 15977639
references.citation: Sci Transl Med. 2012 Jan 11;4(116):116ra4
references.pmid: 22238332
references.citation: Cancer Discov. 2013 May;3(5):512-9
references.pmid: 23539269
references.citation: Science. 2008 Sep 26;321(5897):1807-12
references.pmid: 18772396
references.citation: N Engl J Med. 2005 Mar 10;352(10):997-1003
references.pmid: 15758010
references.citation: Sci Transl Med. 2012 Jan 11;4(116):116ps1
references.pmid: 22238331
references.citation: Acta Neuropathol. 2012 Nov;124(5):615-25
references.pmid: 22886134
references.citation: Acta Neuropathol. 2007 Aug;114(2):97-109
references.pmid: 17618441
references.citation: EMBO J. 2008 Jan 23;27(2):406-20
references.pmid: 18157086
references.citation: Acta Neuropathol. 2009 Nov;118(5):599-601
references.pmid: 19798509
references.citation: PLoS One. 2008 Aug 28;3(8):e3088
references.pmid: 18769486
references.citation: Cancer Cell. 2012 Oct 16;22(4):417-8
references.pmid: 23079650
references.citation: J Clin Oncol. 2007 Apr 1;25(10):1196-208
references.pmid: 17401009
references.citation: Nat Genet. 2012 Jan 29;44(3):251-3
references.pmid: 22286216
references.citation: Cancer Cell. 2012 Oct 16;22(4):425-37
references.pmid: 23079654
references.citation: Science. 2013 May 3;340(6132):626-30
references.pmid: 23558169
references.citation: Eur J Haematol. 2013 Feb;90(2):169-70
references.pmid: 23116151
references.citation: Brain Tumor Pathol. 2011 Jul;28(3):177-83
references.pmid: 21442241
references.citation: Cancer Cell. 2010 Dec 14;18(6):553-67
references.pmid: 21130701
references.citation: Nature. 2012 Aug 2;488(7409):43-8
references.pmid: 22722829
references.citation: Cancer Res. 2009 Dec 15;69(24):9157-9
references.pmid: 19996293
references.citation: Nat Rev Neurol. 2010 Dec;6(12):695-701
references.pmid: 21045797
references.citation: J Clin Oncol. 2009 Dec 1;27(34):5743-50
references.pmid: 19805672
references.citation: Clin Cancer Res. 2011 Jul 15;17(14):4650-60
references.pmid: 21610151
references.citation: Acta Neuropathol. 2012 Apr;123(4):465-72
references.pmid: 22134537
references.citation: Acta Neuropathol. 2011 Mar;121(3):397-405
references.pmid: 21274720
references.citation: Clin Cancer Res. 2007 Nov 1;13(21):6284-92
references.pmid: 17975139
references.citation: Oncogene. 2014 Apr 17;33(16):2019-26
references.pmid: 23624918
references.citation: Neuro Oncol. 2010 Feb;12(2):153-63
references.pmid: 20150382
references.citation: Brain Pathol. 2013 Mar;23(2):210-6
references.pmid: 23432647
references.citation: Am J Clin Pathol. 2013 Mar;139(3):345-9
references.pmid: 23429371
references.citation: Med Sci (Paris). 2012 Oct;28(10):809-12
references.pmid: 23067407
references.citation: Oncotarget. 2012 Oct;3(10):1194-203
references.pmid: 23104868
references.citation: J Clin Oncol. 2010 Jun 20;28(18):3061-8
references.pmid: 20479398
references.citation: Nature. 2012 Aug 30;488(7413):656-9
references.pmid: 22763442
references.citation: Cancer Cell. 2011 Jan 18;19(1):17-30
references.pmid: 21251613
references.citation: Science. 2011 Jul 22;333(6041):425
references.pmid: 21719641
references.citation: Acta Neuropathol. 2012 Sep;124(3):439-47
references.pmid: 22661320
references.citation: PLoS One. 2013 Apr 29;8(4):e61512
references.pmid: 23637844
references.citation: Science. 2011 Jan 28;331(6016):435-9
references.pmid: 21163964
references.citation: Nature. 2008 Oct 23;455(7216):1061-8
references.pmid: 18772890
references.citation: Clin Cancer Res. 2011 Dec 15;17(24):7595-604
references.pmid: 22038996
references.citation: Nature. 2012 Aug 2;488(7409):106-10
references.pmid: 22820256
references.citation: Pediatr Neurosurg. 2005 Nov-Dec;41(6):292-9
references.pmid: 16293948
references.citation: Nature. 2012 Jan 29;482(7384):226-31
references.pmid: 22286061
references.citation: Cell Mol Life Sci. 2012 Jun;69(11):1799-811
references.pmid: 22159586
references.citation: Cancer Cell. 2006 Mar;9(3):157-73
references.pmid: 16530701
references.citation: Oncogene. 2009 May 21;28(20):2119-23
references.pmid: 19363522
references.citation: Childs Nerv Syst. 2011 Jan;27(1):87-94
references.pmid: 20725730
references.citation: N Engl J Med. 2009 Feb 19;360(8):765-73
references.pmid: 19228619
references.citation: N Engl J Med. 2005 Nov 10;353(19):2012-24
references.pmid: 16282176
references.citation: Cancer Cell. 2011 Aug 16;20(2):143-57
references.pmid: 21840481
references.citation: Oncotarget. 2012 Jul;3(7):709-22
references.pmid: 22869205
references.citation: Nature. 2010 Dec 23;468(7327):1095-9
references.pmid: 21150899
references.citation: N Engl J Med. 2005 Mar 10;352(10):987-96
references.pmid: 15758009
references.citation: Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6021-6
references.pmid: 23530248
references.citation: Acta Neuropathol. 2013 May;125(5):659-69
references.pmid: 23417712
references.citation: Nature. 2012 Aug 2;488(7409):49-56
references.pmid: 22832581
references.citation: Sci Transl Med. 2012 Jan 11;4(116):116ra5
references.pmid: 22238333
references.citation: J Clin Oncol. 2010 Nov 10;28(32):4783-9
references.pmid: 20458039